Glyclopyramide
Clinical data | |
---|---|
Routes of administration | Oral |
ATC code | none |
Legal status | |
Legal status |
|
Identifiers | |
| |
CAS Number | 631-27-6 |
PubChem (CID) | 71793 |
ChemSpider | 64820 |
UNII | KE474IKG1W |
KEGG | D01799 |
ChEMBL | CHEMBL2105083 |
Chemical and physical data | |
Formula | C11H14ClN3O3S |
Molar mass | 303.76 g/mol |
3D model (Jmol) | Interactive image |
| |
| |
(what is this?) (verify) |
Glyclopyramide (INN, marketed under the tradename Deamelin-S) is a sulfonylurea drug used in the treatment of diabetes. It has been marketed in Japan since 1965.
It is classified as second generation.[1]
References
- ↑ Ozawa H, Murai Y, Ozawa T (2003). "[A 50-year history of new drugs in Japan-the development and progress of anti-diabetic drugs and the epidemiological aspects of diabetes mellitus]". Yakugaku Zasshi (in Japanese). 38 (1): 11–27. PMID 14570054.
External links
This article is issued from Wikipedia - version of the 8/24/2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.